Close Menu

NEW YORK – Myriad Genetics is partnering with the University of Leeds Center for Personalized Medicine and Health (LCPMH) to conduct a clinical utility study of the Prolaris prostate cancer test.

Prolaris analyzes the expression of 31 cell cycle genes, and may be combined with prostate specific antigen testing and Gleason score to gauge the aggressiveness of a patient's prostate cancer over the next decade.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jun
02
Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.